Epzicom is licensed for the treatment of HIV and AIDS. The medication is not a cure for HIV or AIDS but can stop the virus from infecting healthy cells in the body. It comes in tablet form and is generally taken once a day. While most people tolerate the medicine well, potential side effects include insomnia, headaches, and fatigue.
Epzicom™ (abacavir/lamivudine) is a prescription medication used to treat HIV and AIDS. It is approved for use in combination with other HIV medications. Epzicom contains two different medications: abacavir (Ziagen®, ABC) and lamivudine (Epivir®, 3TC).
Epzicom is made by GlaxoSmithKline.
Epzicom contains two different HIV/AIDS medications: abacavir and lamivudine. They belong to a group of HIV medicines known as nucleoside reverse transcriptase inhibitors (NRTIs). These drugs work by blocking a process that the HIV virus needs in order to multiply.
HIV (human immunodeficiency virus) is the virus that causes AIDS. Like other viruses, it must use a person's own cells to reproduce. However, HIV is a little different from other viruses because it must first convert its genetic material from RNA to DNA. It is the DNA genes that allow HIV to multiply.
HIV converts its genetic material by using a special protein called the reverse transcriptase enzyme. To create DNA, this enzyme uses several different molecular building-blocks.
Epzicom works by tricking reverse transcriptase into thinking it is one of these molecular building-blocks. However, it is just different enough that when used to create DNA, the drug actually stops the DNA from being made. Without DNA, HIV cannot multiply.
Epzicom is not a cure for HIV or AIDS. It can help stop HIV from infecting healthy cells in the body, but it does not help cells that have already been infected with the virus.